Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models.
针对耐药结核分枝杆菌持续感染者的免疫疗法可加速临床前模型中结核病的治愈。
期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI196648
Karanika Styliani, Wang Tianyin, Yilma Addis, Ruelas Castillo Jennie, Gordy James T, Bailey Hannah, Quijada Darla, Fessler Kaitlyn, Tasneen Rokeya, Rouse Salcido Elisa M, Shamma Farah, Harris Harley T, Chen Fengyixin, Bates Rowan E, Ton Heemee, Meza Jacob, Li Yangchen, Taylor Alannah D, Zheng Jean J, Zhang Jiaqi, Karantanos Theodoros, Maxwell Amanda R, Nuermberger Eric, Peske J David, Markham Richard B, Karakousis Petros C
